Showing results (161-170 of 443) with videos related to
Sort By:
Pageof 45
Analytical Chemistry|August 6, 2019
Toward Single-Organelle Lipidomics in Live CellsAdrian Lita, Andrey N Kuzmin, Artem Pliss, et al.Cancer|February 27, 2010
Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patientsLindsay Kilburn, M Fatih Okcu, Tao Wang, et al.Neuro-Oncology|April 16, 2005
Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic studySurasak Phuphanich, Sharyn D Baker, Stuart A Grossman, et al.Neuro-Oncology Advances|January 27, 2026
Fusion transcriptome landscape in glioblastoma: Incidence and therapeutic implicationsSonikpreet Aulakh, Joanne Xiu, Shawn Kothari, et al.Journal of Pain and Symptom Management|August 5, 2008
Clinical utility of the MDASI-BT in patients with brain metastasesTerri S Armstrong, Ibrahima Gning, Tito R Mendoza, et al.Journal of Neuro-Oncology|October 3, 2013
Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysisAmol J Ghia, Anita Mahajan, Pamela K Allen, et al.Journal of Patient-Reported Outcomes|August 25, 2019
Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviewsAlvina A Acquaye, Samuel S Payén, Elizabeth Vera, et al.International Journal of Molecular Sciences|July 29, 2023
TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal CarcinomaNiranjana Amin, Herui Wang, Qi Song, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activityMonika E Hegi, Lili Liu, James G Herman, et al.Research Square|March 3, 2023
Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trialAmanda L King, Alvina A Acquaye, Tito Mendoza, et al.Pageof 45